venlafaxine hydrochloride

Generic: venlafaxine

Labeler: xlcare pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine
Labeler xlcare pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
XLCare Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 72865-199
Product ID 72865-199_2cdc9267-9619-474a-abe4-a0b85ac3fb2d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214419
Listing Expiration 2026-12-31
Marketing Start 2021-02-26

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72865199
Hyphenated Format 72865-199

Supplemental Identifiers

RxCUI
808744 808748 808751 808753
UPC
0372865198902 0372865199909 0372865197301 0372865198308 0372865200308 0372865200902 0372865199305 0372865197905
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine (source: ndc)
Application Number ANDA214419 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-199-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-199-90)
source: ndc

Packages (2)

72865-199-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-199-30) 72865-199-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-199-90)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

VENLAFAXINE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2cdc9267-9619-474a-abe4-a0b85ac3fb2d", "openfda": {"upc": ["0372865198902", "0372865199909", "0372865197301", "0372865198308", "0372865200308", "0372865200902", "0372865199305", "0372865197905"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["68f40801-d35e-464e-ac94-21016b617ea2"], "manufacturer_name": ["XLCare Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-199-30)", "package_ndc": "72865-199-30", "marketing_start_date": "20210226"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-199-90)", "package_ndc": "72865-199-90", "marketing_start_date": "20210226"}], "brand_name": "VENLAFAXINE HYDROCHLORIDE", "product_id": "72865-199_2cdc9267-9619-474a-abe4-a0b85ac3fb2d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "72865-199", "generic_name": "venlafaxine", "labeler_name": "XLCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VENLAFAXINE HYDROCHLORIDE", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA214419", "marketing_category": "ANDA", "marketing_start_date": "20210226", "listing_expiration_date": "20261231"}